TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,712,460 | -69.0% | 254,000 | -71.0% | 0.03% | -65.6% |
| Q4 2022 | $18,443,310 | -1.0% | 877,000 | +16.0% | 0.09% | -1.1% |
| Q3 2022 | $18,628,000 | +147.6% | 756,000 | +143.5% | 0.09% | +175.8% |
| Q2 2022 | $7,523,000 | +35.5% | 310,500 | +44.1% | 0.03% | +73.7% |
| Q1 2022 | $5,553,000 | -66.1% | 215,500 | -59.2% | 0.02% | -45.7% |
| Q4 2021 | $16,389,000 | +150.7% | 528,000 | +95.8% | 0.04% | +118.8% |
| Q3 2021 | $6,538,000 | +64.8% | 269,600 | -0.9% | 0.02% | +77.8% |
| Q2 2021 | $3,968,000 | – | 272,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
| Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
| Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
| GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
| ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
| HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
| MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
| Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
| Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |